Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection-Reference-Cited by-同舟云学术

Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection

Published:2008-12-10 Issue:3 Volume:13 Page:146-150
ISSN:0106-9543
Container-title:Liver
language:en
Short-container-title:

Author:

Milella Michele,Antoneill Guido,Santantonio Teresa,Currenti Maurizio,Monno Laura,Mariano Nicola,Angarano Gioacchino,Dianzanl Ferdinando,Pastors Giuseppe

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0676.1993.tb00622.x/fullpdf

Reference15 articles.

1. Changes of HBV markers in serum and liver tissue in patients with chronic hepatitis B treated with recombinant alpha-interferon (rIFN-a): results of a controlled study;Pastore;Antiviral Chem Chemother,1990

2. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon;Carreno;Liver,1987

3. Randomised controlled trial of interferon alfa2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response;Brook;GUT,1989

4. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial;Davis;N Engl J Med,1989

5. Anti-IFN-a titres during interferon therapy;Inglada;Lancet,1987

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN Trials;Hepatology;2024-04-17

2. Intralesional interferon alpha-2b as a novel treatment for periocular squamous cell carcinoma in horses;PLOS ONE;2024-02-21

3. Anti-cytokine autoantibodies: mechanistic insights and disease associations;Nature Reviews Immunology;2023-09-19

4. ADME of Biologicals and New Therapeutic Modalities;Reference Module in Biomedical Sciences;2021

5. Immunogenicity of branched polyethylene glycol modified interferon alpha;Immunopharmacology and Immunotoxicology;2017-11-06